“…Although SARS-CoV-2 evolution is more obvious in the accumulation of mutations that increase infectivity or evade neutralizing antibodies (55), some level of T cell evasion is also detectable. Thus, mutations in several HLA class I-restricted SARS-CoV-2 epitopes besides YLQ were found to potentially enable the virus to escape killing by cytotoxic CD8 + T cells (17) and it is predicted that emerging variants of concern such as the UK (Alpha), South African (Beta), and Indian (Delta) variants have a substantial number of peptides with decreased binding to common HLA class I alleles (56). However, as T cell responses to SARS-CoV-2 are targeted to multiple epitopes simultaneously (6,10,13,17,(24)(25)(26)(27)(28)(29)(30)(31)(32)(33), it is not expected any single mutation can radically influence the overall magnitude of the response, an important consideration in vaccine development.…”